Zheng Quan Ri Bao·2026-01-08 03:58Core Insights - Alibaba Health and Beijing Melson Pharmaceutical Technology Development Co., Ltd. have formed a strategic partnership to collaborate in the field of innovative drugs for pediatric specialties, specifically focusing on the treatment of infantile hemangiomas with the topical drug Beimeijing® [1][2] Group 1: Product and Market Context - Beimeijing® (timolol maleate gel) is the world's first approved topical innovative drug for the treatment of proliferative superficial infantile hemangiomas, addressing a significant clinical need in the pediatric market [1] - The global incidence of infantile hemangiomas is estimated to be between 5% and 12%, with superficial types accounting for nearly 70% of cases [1] - A meta-analysis by the Chinese Medical Association indicates that 25% to 69% of untreated children may experience long-term issues such as scarring and skin laxity, particularly affecting areas like the head and face, which can impact psychological health and social interactions [1] Group 2: Clinical Trial Results - In a pivotal Phase III clinical trial involving 121 infants aged 1-6 months, Beimeijing® demonstrated a clinical cure rate of 60.7% and an overall efficacy rate of 89.4% after 24 weeks of treatment, with good safety profiles [2] Group 3: Strategic Initiatives and Future Plans - Beimeijing® is set to launch exclusively on Alibaba Health's platform on January 13, with plans to initiate the "Infant Hemangioma Care Program," which will include expert consultations, educational live streams, medication guidance communities, and charitable assistance projects [2] - The collaboration aims to integrate Alibaba Health's ecosystem capabilities with Melson's expertise in pediatric specialty research, enhancing health management solutions for children and promoting industry standards [2] - Alibaba Health emphasizes that this partnership is a key step in deepening its vertical disease management capabilities, focusing on patient-centered strategies to maximize the value of treatment solutions like Beimeijing® [2]